Prognostic and predictive value of phospho-c-Jun expressionin hepatocellular carcinoma patients treated with sorafenib
Annals of Clinical and Analytical Medicine · 01.05.2026 · 17 (5) · 472-477
DOI: 10.4328/acam.22838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Analytical Medicine, erschienen am 01.05.2026. Verfasst von Ergin Aydemir und 4 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Aim
Hepatocellular carcinoma (HCC) is a highly lethal malignancy with limited treatment options at advanced stages. Sorafenib, a multikinase inhibitor, remains a key systemic therapeutic agent; however, treatment response varies significantly among patients. This study aimed to investigate phospho-c-Jun (PCJ) expression as a potential biomarker for sorafenib resistance and its association with survival outcomes in HCC patients.
Methods
This retrospective study analyzed 32 HCC patients who received first-line sorafenib therapy between September 2020 and January 2021. Immunohistochemical analysis was performed to determine nuclear phospho-c-Jun expression levels. Patients were categorized based on H-score (≥87.5 vs
Zitieren
APA
Aydemir, E., İnan, M. A., İnci, B. K., Esendağlı, G., & Üner, A. (2026). Prognostic and predictive value of phospho-c-Jun expressionin hepatocellular carcinoma patients treated with sorafenib. Annals of Clinical and Analytical Medicine, 17(5), 472-477. https://doi.org/10.4328/acam.22838
Vancouver
Aydemir E, İnan MA, İnci BK, Esendağlı G, Üner A. Prognostic and predictive value of phospho-c-Jun expressionin hepatocellular carcinoma patients treated with sorafenib. Annals of Clinical and Analytical Medicine. 2026;17(5):472-477. doi:10.4328/acam.22838
BibTeX
@article{Aydemir2026,
author = {Aydemir, Ergin and İnan, Mehmet Arda and İnci, Bediz Kurt and Esendağlı, Güldal and Üner, Aytuğ},
title = {Prognostic and predictive value of phospho-c-Jun expressionin hepatocellular carcinoma patients treated with sorafenib},
journal = {Annals of Clinical and Analytical Medicine},
year = {2026},
volume = {17},
number = {5},
pages = {472--477},
doi = {10.4328/acam.22838}
}
EUVIMED